Replies to post #189971 on Biotech Values

[biocqr]

Yes... two sides of the same coin but only one side is a valid endpoint... right? You said the doubling the distance is the threshold... the Lucentis P3 trials say otherwise.

Doubling the distance is much harder to achieve than not halving the distance... agree?